Interactions between Retroviruses and the Host Cell Genome.

Area of Science:

• Genetics and Genomics
• Molecular Biology
• Biotechnology

Background:

• Replication-defective retroviral vectors are established tools for gene therapy, facilitating stable transgene insertion into human cells.
• Successful treatments for genetic diseases using autologous hematopoietic stem-progenitor cells (HSPCs) transduced with retroviral vectors exist, with Strimvelis gaining European market authorization.
• Past clinical trials reported severe adverse events due to vector-induced proto-oncogene activation, highlighting the genotoxic potential of proviral integration.

Purpose of the Study:

• To review current knowledge on retrovirus-host interactions at the genomic level.
• To elucidate the mechanisms of retroviral and gene transfer vector integration into the human genome.
• To provide a foundation for developing safer and more effective retroviral vectors for gene therapy.

Main Methods:

• Literature review of retroviral biology and gene therapy.
• Analysis of molecular mechanisms underlying retroviral integration site selection.
• Examination of retrovirus-host interactions at the genomic level.

Main Results:

• Significant advancements in understanding retroviral integration site selection in mammalian genomes.
• Detailed insights into how different retroviruses and gene transfer vectors interact with and integrate into the human genome.
• Identification of genotoxic potential linked to proviral integration.

Conclusions:

• Knowledge of retroviral integration mechanisms is crucial for enhancing gene therapy safety.
• Further research into retrovirus-host genomic interactions will drive the development of improved gene therapy vectors.
• The goal is to create safer and more efficacious retroviral vectors for treating genetic disorders.